Journal of Viral Hepatitis

(ISSN: 1352-0504, 1365-2893)

Subscribe Submit

Table of Contents

2021 - 28 (2)

  • A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction. 
  • Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcome. 
  • Variceal recurrence 4 years post endoscopic band ligation in hepatitis C patients who achieved sustained virological response with oral direct-acting antiviral therapy. 
  • Comparison of viral control between two tenofovir dose reduction regimens (300 mg every 48 hours versus 300 mg every 72 hours) in chronic hepatitis B patients with moderate renal impairment from tenofovir-induced renal dysfunction. 
 
 

Journal Information

Mission Statement: The Journal of Viral Hepatitis is a bimonthly journal, publishing reviews, original work (full papers) and short rapid communications in the area of viral hepatitis.